Neogenomics (NEO) Cash & Equivalents Growth (5y) (2015 - 2026)
Neogenomics (NEO) Cash & Equivalents Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Neogenomics | 2.05 Bn | 1.90 Bn | 91.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.97% |
| Mar 31, 2026 | -24.91% |
| Dec 31, 2025 | -6.94% |
| Sep 30, 2025 | -6.79% |
| Jun 30, 2025 | -12.13% |
| Mar 31, 2025 | 32.04% |
| Dec 31, 2024 | 16.23% |
| Sep 30, 2024 | 15.14% |
| Jun 30, 2024 | 16.22% |
| Mar 31, 2024 | 90.60% |
| Dec 31, 2023 | 103.51% |
| Sep 30, 2023 | 20.92% |
| Jun 30, 2023 | 98.27% |
| Mar 31, 2023 | 78.58% |
| Dec 31, 2022 | 83.01% |
| Sep 30, 2022 | 85.21% |
| Jun 30, 2022 | 91.78% |
| Mar 31, 2022 | 94.34% |
| Dec 31, 2021 | 90.81% |
| Sep 30, 2021 | 63.74% |